argenx SE — News

$865 USD

$0 (0.0%)

Source	Headline
	Argenx to Buy Forte Biosciences for $2.2 Billion The deal to acquire the Nasdaq-listed Forte represents a 41% premium to its closing price on Friday. wsj.com - 2026-07-27 01:29:00
	Argenx to buy Forte Biosciences for about $2.2 billion Belgian-Dutch immunology company argenx will buy ‌Forte Biosciences to add experimental autoimmune drug FB102 to its portfolio, ⁠the company said on Monday. reuters.com - 2026-07-27 01:15:45
	Argenx's Vyvgart sales jump in second quarter Belgian-Dutch immunology company argenx said on Thursday global sales of its lead ‌drug Vyvgart jumped in the second quarter of 2026 from a year earlier. reuters.com - 2026-07-23 01:41:31
	Sanofi, An Argenx Rival, Bites The Dust — But A Third Biotech Took The Biggest Hit Sanofi scrapped a final-phase study Wednesday of an experimental CIDP treatment. The stock tumbled in response. investors.com - 2026-06-10 10:15:51

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

Date	Analyst Firm	Action	Previous Grade	New Grade
2023-10-01	Truist Securities	Maintain	Buy	Buy
2023-09-17	HC Wainwright & Co.	Maintain	Buy	Buy
2023-08-30	Piper Sandler	Maintain	Overweight	Overweight
2023-07-27	Wells Fargo	Maintain	Overweight	Overweight
2023-07-27	HC Wainwright & Co.	Maintain	Buy	Buy
2023-07-27	Guggenheim	Maintain	Buy	Buy
2023-07-23	Piper Sandler	Maintain	Overweight	Overweight
2023-07-23	UBS	Downgrade	Buy	Neutral
2023-07-20	HC Wainwright & Co.	Maintain	Buy	Buy
2023-07-19	Morgan Stanley	Maintain	Overweight	Overweight
2023-07-17	HC Wainwright & Co.	Maintain	Buy	Buy
2023-07-17	Raymond James	Maintain	Strong Buy	Strong Buy
2023-07-17	Citigroup	Maintain	Buy	Buy
2023-07-17	Guggenheim	Maintain	Buy	Buy
2023-07-17	Wedbush	Maintain	Outperform	Outperform
2023-07-16	Jefferies	Maintain	Buy	Buy
2023-07-16	HC Wainwright & Co.	Maintain	Buy	Buy
2023-06-21	HC Wainwright & Co.	Maintain	Buy	Buy
2023-06-20	HC Wainwright & Co.	Maintain	Buy	Buy
2023-06-20	Wedbush	Maintain	Outperform	Outperform
2023-06-06	HC Wainwright & Co.	Maintain	Buy	Buy
2023-05-04	Truist Securities	Maintain	Buy	Buy
2023-05-04	JMP Securities	Maintain	Market Outperform	Market Outperform
2023-05-04	Morgan Stanley	Maintain	Overweight	Overweight
2023-05-04	HC Wainwright & Co.	Maintain	Buy	Buy
2023-05-04	Raymond James	Maintain	Strong Buy	Strong Buy
2023-03-19	HC Wainwright & Co.	Maintain	Buy	Buy
2023-03-02	JMP Securities	Maintain	Market Outperform	Market Outperform
2023-03-02	SVB Leerink	Maintain	Outperform	Outperform
2023-02-22	Piper Sandler	Maintain	Overweight	Overweight